RESUMEN

Hepatorenal syndrome (HRS) is a life-treating complication of liver diseases. This functional kidney impairment is classified into acute (type I) and chronic (type II) types and is connected with high mortality. Treatment options are limited, but administration of vasoconstrictors (terlipressin), albumin and portosystemic shunt may improve their prognosis. Liver transplantation is the most effective method for these patients. Authors want to present recent data relating to HRS, including therapeutic recommendations.

Asunto(s)

Síndrome Hepatorrenal/terapia , Síndrome Hepatorrenal/diagnóstico , Síndrome Hepatorrenal/fisiopatología , Humanos , Trasplante de Hígado , Lipresina/análogos & derivados , Lipresina/uso terapéutico , Derivación Portosistémica Quirúrgica , Pronóstico , Terlipresina , Vasoconstrictores/uso terapéutico